KNTE

Kinnate Biopharma Inc. Common Stock
KNTE

Overview Fund Activity
Delisted

KNTE was delisted on the 2nd of April, 2024.

Back to rankings

62 hedge funds and large institutions have $1.18B invested in Kinnate Biopharma Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 18 closing their positions.

Holders
62
Holders Change
+7
Holders Change %
+12.73%
% of All Funds
1.09%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
25
Increased
13
Reduced
9
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$37.7M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$40.7M
3
LGM
3
Logos Global Management
California
$29.1M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$7.43M
5
State Street
5
State Street
Massachusetts
$5.71M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$65.1M
2
EAM
2
Eventide Asset Management
Massachusetts
$0
3
Invesco
3
Invesco
Georgia
$0
4
Millennium Management
4
Millennium Management
New York
$0
5
PHS
5
PFM Health Sciences
California
$8.24M
Name Holding Trade Value Shares
Change 		Shares
Change %
FCMI
1
Foresite Capital Management IV
California
$301M – – –
O
2
OrbiMed
New York
$120M – – –
RCM
3
RA Capital Management
Massachusetts
$112M – – –
VVA
4
Vida Ventures Advisors
Massachusetts
$85.6M +$11.2K +359 +0%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$65.1M -$9.73M -318,487 -13%
Viking Global Investors
6
Viking Global Investors
Connecticut
$58.3M – – –
VA
7
VR Adviser
New York
$45.9M – – –
Citadel Advisors
8
Citadel Advisors
Florida
$41M +$4.67K +150 +0%
Vanguard Group
9
Vanguard Group
Pennsylvania
$40.7M +$14.1M +454,083 +53%
BlackRock
10
BlackRock
New York
$37.7M +$28.1M +900,654 +291%
BC
11
Boxer Capital
California
$33.2M +$39.7K +1,274 +0.1%
LGM
12
Logos Global Management
California
$29.1M +$11.4M +365,000 +64%
FCMV
13
Foresite Capital Management V
California
$27.3M – – –
Janus Henderson Group
14
Janus Henderson Group
United Kingdom
$24.3M -$167K -5,495 -0.7%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$20.2M -$19.4K -624 -0.1%
HMC
16
Harvard Management Company
Massachusetts
$15.5M – – –
DM
17
Deerfield Management
New York
$10.8M – – –
RSCM
18
Rock Springs Capital Management
Maryland
$10.2M +$53K +1,700 +0.5%
Federated Hermes
19
Federated Hermes
Pennsylvania
$9.59M +$1.8M +57,800 +23%
NHAS
20
Novo Holdings A/S
Denmark
$9.35M – – –
WP
21
Woodline Partners
California
$8.92M +$302K +9,678 +4%
PHS
22
PFM Health Sciences
California
$8.24M -$2.42M -77,612 -23%
FCM
23
Farallon Capital Management
California
$7.79M – – –
Geode Capital Management
24
Geode Capital Management
Massachusetts
$7.43M +$6.52M +209,101 +709%
State Street
25
State Street
Massachusetts
$5.71M +$5.71M +183,282 New
1
2 3 4